| 英文别名 |
Clofazimine;N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine;Clofazimine-d7;N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine;2-(4-Chlor-anilino)-5-(4-chlor-phenyl)-3-isopropylamino-phenazinium-betain;2-(4-chloro-anilino)-5-(4-chloro-phenyl)-3-isopropylamino-phenazinium-betaine;B 663 (Pharmaceutical);Chlofazimine;Clo;Clofazimina;Clofazimina [INN-Spanish];Clofazimine (N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine;Clofaziminum;Clofaziminum [INN-Latin];Lampren;Lamprene;HMS1569K13;NSC-141046;N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine;Pharmakon1600-01505974;2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-;WDQPAMHFFCXSNU-KRUMMXJUSA-N;2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-;Lamprene (TN);HMS2096K13;NCGC00016600-07;CLOFAZIMINE [USAN];KUC109573N;3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin;HY-B1046;MLS000028617;CLOFAZIMINUM [WHO-IP LATIN];SMR000058704;SW196840-4;A814428;CLOFAZIMINE [MI];EN300-21680301;B 663, pharmaceutical;MMV687800;2030-63-9;HMS3394B05;BRN 0060420;BDBM50378783;Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard;C06915;2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-;NCGC00179529-01;D00278;EN300-267815;N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #;Z2037279473;B 663;B 663 (VAN);B. 663;3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine;Prestwick_685;CCG-269477;Clofazimine [USAN:USP:INN:BAN];NCGC00016600-01;SCHEMBL5663361;CLOFAZIMINE [VANDF];B-663;NSC 141046;3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German];HMS3652A16;SMR004701474;4-25-00-03033 (Beilstein Handbook Reference);SR-05000001807;NCGC00016600-09;Clofazimine (JAN/USP/INN);CLOFAZIMINE [USP IMPURITY];AKOS015896438;CHEMBL1292;SCHEMBL26757;Clofazimine, European Pharmacopoeia (EP) Reference Standard;CS-4567;MFCD00056793;(4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine;N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine;AMY22515;D959AE5USF;Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-;3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine;EINECS 217-980-2;CLOFAZIMINE [JAN];MLS006010789;BPBio1_000585;HMS3713K13;NCGC00016600-03;SCHEMBL26758;HMS2052B05;GTPL9184;DB00845;NCGC00016600-02;CPD000058704;3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine;2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-;NCGC00016600-04;HMS2231B04;NSC-759283;DTXSID7022839;(3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine;Phenazine,10-dihydro-2-(isop... |